Prevalence of exclusive breastfeeding in Iran: Systematic review and meta-analysis

Background and aims: The World Health Organization and United Nations Children’s Fund (UNICEF) recommended executive breastfeeding for 6 months after birth. The purpose of this study was to determine the prevalence of executive breastfeeding in Iran by a meta-analysis study to be used by policy-makers in order to health programmer plan in this field. Methods: In this meta-analysis study, the databases of ISI Web of Knowledge, PubMed, Science Direct, Scopus, Google Scholar and domestic databases were searched between January 2007 and March 2015. Between the studies with regard to the inclusion and exclusion criteria, 16 studies were selected. Data were analyzed using Stata 11 software. Results: Sever heterogeneity was observed among reported prevalence based on the results of Chi-square based on Q test and I2 statistics (Q=6132.55, P2=99.8 ) and consequently, random effect model was used for themeta-analysis. The overall estimated prevalence of exclusive breastfeeding in Iran was 49.1 (95 CI: 33.4-64.9). Conclusions: In the present study, it was summarized the results of previous studies and showed that the prevalence of exclusive breastfeeding in Iran has been increased and currently is in a satisfactory level. The ongoing national programs for preservation and promoting of exclusive breastfeeding should continue

Trends in the Timing and Magnitude of Flood in the Large Karoun River Basin

Source: ICHE Conference Archive - https://mdi-de.baw.de/icheArchiv

Epidemiological study of cholera in Qazvin city during summer of 2011

Cholera is an acute intestinal infection caused by consuming food or water contaminated with the bacterium Vibrio cholerae. Two main epidemiological characteristic of disease is tendency for create of sudden outbreaks and the ability to causing a pandemic. The objective of this study is to describe the epidemiology of the disease. This survey is a descriptive cross-sectional study based on reports from the health centers and hospitals covered by city health centers. Rectal swab is obtained from all suspected cases. After reporting each positive case, health team was sent to the location and it completed the epidemiological form. Data were analyzed by version 16 of SPSS software. All reported patients were 44 cases. Epidemic lasted from 4 August to 18 September 2011. Ogawa was the predominant pathogenic serosubtype. 47.7% of all patients admitted to the hospital and 52.3% were treated as outpatients. Most of the patients were in age group >60 years and there were no reports of disease in age group under 15 years.  2 of the 44 patients had mild symptoms of diarrhea, 13 patients had moderate and 29 cases had severe diarrhea. Not affection of age groups less than 15 years indicates epidemic patterns of disease in the city. Severity of symptoms is important in case finding; then, in disease surveillance system we should obtain rectal swab specimen from all cases of diarrhea with severe symptoms.

Bioinformatics-Guided Discovery of miRNAs Involved in Apoptosis Modulated by Parthenolide Combined with Vincristine in The NALM6 Cell Line

Objective: Acute lymphoblastic leukemia (ALL) is a highly heterogeneous leukemia. Despite the current improvement inconventional chemotherapy and high survival rates, the outcomes remain challenging. Sesquiterpen extracted from theTanacetum parthenium, parthenolide, is a potential anticancer agent that can modulate the expression of miRNAs and induceapoptosis. The objective of this study was to investigate the effect of parthenolide in combination with vincristine and alone onthe apoptosis rate and expression of miR-125b-5p, miR-181b-5p, and miR-17-5p in the NALM6 cell line.Materials and Methods: In this experimental study, cell viability and metabolic activity were determined through MTTassay and PI staining. Flow cytometry was applied to evaluate the rate of apoptosis. The expression of miRNAs wasassessed using real-time polymerase chain reaction. Bioinformatic analyses, including Cytoscape, RNAhybrid, andsignaling pathway analysis were employed to investigate the association of miR-17-5p, miR-181b-5p and miR-125b-5p with apoptosis. Further, molecular docking served to validate the modulation of these miRNAs by parthenolide andvincristine treatment.Results: The MTT assay indicated that 7.7 μM of parthenolide decreased the metabolic activity to 50% after 48 hours. PIstaining analysis indicated that at concentrations below the half maximal inhibitory concentration, parthenolide caused50% cell death. Flow cytometric analysis indicated that parthenolide (1.925 μM) in combination with vincristine (1.2 nM)induced apoptosis in 83.2% of the cells. Real-time quantitative reverse transcription polymerase chain reaction (qRTPCR)analysis showed significant changes in the expression levels of miR-17-5p, miR-125b-5p, and miR-181b-5p.Moreover, the combination therapy downregulated the expression of miRNAs significantly. This was consistent with ourbioinformatic analysis demonstrating that the studied miRNAs are regulators of apoptosis. Finally, molecular dockingvalidated the modulation of the miRNAs by parthenolide and vincristine.Conclusion: Parthenolide in combination with vincristine triggers apoptosis at a high rate in the NALM6 cell line.Moreover, this combination therapy can decrease the expression of miR-17-5p, miR-181b-5p, and miR-125b-5p

Evaluation of Flow Cytometry and Kleihauer Techniques for Quantification of Fetomaternal Hemorrhage: A Prospective Cohort Study in Southwestern Iran

Background: Quantification of fetal red blood cells (RBCs) in maternal blood is of great importance to calculate appropriate dose of post-deliver anti D immunoglobulin in a rhesus D (RhD)-negative woman. Objective: The aim of this study is to evaluate a direct immunofluorescence flow cytometry technique in artificial and clinical samples and compared it to the Kleihauer-Betke test (KBT). Methods: This study was a prospective cohort design. Blood samples from 26 pregnant women who gave birth to RhD positive babies were tested using direct immunofluorescence flow cytometry and KBT techniques to determine the amount of FMH in the maternal circulation. The zone of D-positive cells was identified employing artificial samples including 0.3%, 0.6%, 1%, 1.5%, 2%, 5%, 10%, and 50% of D-positive fetal cells in D-negative maternal cells. Results: Analysis of 26 clinical samples for FMH showed consistent quantification with the flow cytometry and Kleihauer techniques. Although a good correlation was found between the KBT and flow cytometry results, in artificial samples containing more than 2% of fetal RhD positive cells, the flow cytometry results were closer to theoretical percentages. In a patient with FMH >4 mL, the FMH and consequently the required vial of Ig were overestimated using KBT. Conclusion: Most of the FMH calculated could have been neutralized by doses less than 625 IU, whereas the routine dose in Iran is more than double that amount (1500 IU). This achievement demonstrates that adjusting between the RhD immune globulin (RhDIg) dose and FMH size is inevitable

Association of weekly or biweekly use of 50.000 IU vitamin D3 with hypervitaminosis D

Since the beginning of COVID-19 pandemic, many Iranian people are taking 50.000 IU of vitamin D3 on the weekly or biweekly bases in order to enhance their immune system function. This cross- sectional study was conducted on the patients of endocrinology clinic to compare 25(OH)D levels of weekly or biweekly consumption with the monthly users of vitamin D3 50,000 IU. The level above 100ng/ml of 25(OH)D was defined as hypervitaminosis D. Totally, 211 patients (108 and 103 patients in monthly and weekly/ biweekly groups, respectively) were studied. In the subgroups of weekly and biweekly users, the rates of hypervitaminosis were 18.9% and 4.5%, respectively. In contrast, only 0.9% of monthly users had hypervitaminosis D. The highest vitamin D value of 185 ng/ml was detected in a patient who consumed 50,000 IU vitamin D3 weekly for 6 years. No hypercalcemia was detected in the patients with hypervitaminosis D

Association of weekly or biweekly use of 50 000 IU vitamin D3 with hypervitaminosis D

Since the beginning of the COVID-19 pandemic, many Iranian people have been taking 50 000 IU of vitamin D3 on weekly or biweekly bases in order to enhance their immune system function. This cross-sectional study was conducted on the patients of endocrinology clinic to compare 25(OH)D levels of weekly or biweekly consumption with the monthly users of vitamin D3 50 000 IU. The level >100 ng/mL of 25(OH)D was defined as hypervitaminosis D. In total, 211 patients (108 and 103 patients in monthly and weekly/biweekly groups, respectively) were studied. In the subgroups of weekly and biweekly users, the rates of hypervitaminosis were 18.9% and 4.5%, respectively. In contrast, only 0.9% of monthly users had hypervitaminosis D. The highest vitamin D value of 185 ng/mL was detected in a patient who had consumed 50 000 IU vitamin D3 weekly for 6 years. No hypercalcaemia was detected in patients with hypervitaminosis D

Contributing Factors for Calcium Changes During Hospitalization in COVID-19: A Longitudinal Study

Abstract Background: Hypocalcemia is highly prevalent in Coronavirus disease 2019 (COVID-19). There is limited evidence about the course and roles of different parameters in the occurrence of new or worsening hypocalcemia. Objectives: This prospective longitudinal study was conducted on hospitalized COVID-19 patients in Qazvin, Iran, in 2021. Methods: Serum levels of calcium, albumin, parathormone (PTH), 25(OH)D (vitamin D), magnesium, and phosphate were assessed on the first day (time one), as well as fourth to sixth days (time two) of hospitalization. Paired t-test, McNemar’s test, and multivariate logistic regression test were used to compare data at two times and evaluating the independent roles of different variables in the occurrence or worsening of hypocalcemia. Results: Out of a total of 123 participants, 102 patients completed the study. The mean serum calcium level significantly decreased from 8.32 ± 0.52 mg/dL to 8.02 ± 0.55 mg/dL at time two compared to time one (P < 0.001). Also, we witnessed new or worsening hypocalcemia at time two in 44 (55%) patients with normal serum calcium or mild hypocalcemia at time one (P < 0.001). The PTH level decreased from 42.17±27.20 pg/mL to 31.28±23.42 pg/mL (P < 0.001). The decrease in albumin and PTH levels was an independent significant factor in the occurrence or worsening of hypocalcemia at time two (OR = 1.27; 95% CI: 1.10 - 1.46; P = 0.001 for each 1 g/L decrement albumin and OR = 1.29; 95% CI: 1.03 - 1.62; P = 0.026 for each 10 pg/mL decrement PTH). Vitamin D deficiency or changes during hospitalization did not have a significant role in new or worsening hypocalcemia. Conclusions: Decreased PTH secretion and hypoalbuminemia have significant roles in the occurrence of new or worsening hypocalcemia during hospitalization due to COVID-19. Keywords: Hypocalcemia, COVID-19, Parathormone, Vitamin